Shahnaz Khan1,2, David Chambers3, Gila Neta3. 1. School of Medicine and Health Sciences, The George Washington University, Washington, DC, 20006, USA. kshahnaz@gwmail.gwu.edu. 2. Division of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health, Rockville, MD, 20850, USA. kshahnaz@gwmail.gwu.edu. 3. Division of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health, Rockville, MD, 20850, USA.
Abstract
PURPOSE: Previous studies estimate translation of research evidence into practice takes 17 years. However, this estimate is not specific to cancer control evidence-based practices (EBPs), nor do these studies evaluate variation in the translational process. We examined the translational pathway of cancer control EBPs. METHODS: We selected five cancer control EBPs where data on uptake were readily available. Years from landmark publication to clinical guideline issuance to implementation, defined as 50% uptake, were measured. The translational pathway for each EBP was mapped and an average total time across EBPs was calculated. RESULTS: Five cancer control EBPs were included: mammography, clinicians' advice to quit smoking, colorectal cancer screening, HPV co-testing, and HPV vaccination. Time from publication to implementation ranged from 13 to 21 years, averaging 15 years. Time from publication to guideline issuance ranged from 3 to 17 years, and from guideline issuance to implementation, - 4 to 12 years. Clinician's advice to quit smoking, HPV co-testing, and HPV vaccination were most rapidly implemented; colorectal cancer screening and mammography were slowest to implement. CONCLUSION: The average time to implementation was 15 years for the five EBPs we evaluated, a marginal improvement from prior findings. Although newer EBPs such as HPV vaccination and HPV co-testing were faster to implement than other EBPs, continued efforts in implementation science to speed research to practice are needed.
PURPOSE: Previous studies estimate translation of research evidence into practice takes 17 years. However, this estimate is not specific to cancer control evidence-based practices (EBPs), nor do these studies evaluate variation in the translational process. We examined the translational pathway of cancer control EBPs. METHODS: We selected five cancer control EBPs where data on uptake were readily available. Years from landmark publication to clinical guideline issuance to implementation, defined as 50% uptake, were measured. The translational pathway for each EBP was mapped and an average total time across EBPs was calculated. RESULTS: Five cancer control EBPs were included: mammography, clinicians' advice to quit smoking, colorectal cancer screening, HPV co-testing, and HPV vaccination. Time from publication to implementation ranged from 13 to 21 years, averaging 15 years. Time from publication to guideline issuance ranged from 3 to 17 years, and from guideline issuance to implementation, - 4 to 12 years. Clinician's advice to quit smoking, HPV co-testing, and HPV vaccination were most rapidly implemented; colorectal cancer screening and mammography were slowest to implement. CONCLUSION: The average time to implementation was 15 years for the five EBPs we evaluated, a marginal improvement from prior findings. Although newer EBPs such as HPV vaccination and HPV co-testing were faster to implement than other EBPs, continued efforts in implementation science to speed research to practice are needed.
Entities:
Keywords:
Cancer control; Evidence-based practice; Implementation; Translation; Uptake
Authors: Michelle I Silver; Anne F Rositch; Darcy F Phelan-Emrick; Patti E Gravitt Journal: Cancer Causes Control Date: 2017-11-09 Impact factor: 2.506
Authors: Michael Pignone; Melissa Rich; Steven M Teutsch; Alfred O Berg; Kathleen N Lohr Journal: Ann Intern Med Date: 2002-07-16 Impact factor: 25.391
Authors: Sheree R Schwartz; Joel Chavez Ortiz; Justin D Smith; Laura K Beres; Aaloke Mody; Ingrid Eshun-Wilson; Nanette Benbow; Deepthi P Mallela; Stephen Tan; Stefan Baral; Elvin Geng Journal: J Acquir Immune Defic Syndr Date: 2022-07-01 Impact factor: 3.771
Authors: Enola Proctor; Alex T Ramsey; Lisa Saldana; Thomas M Maddox; David A Chambers; Ross C Brownson Journal: Glob Implement Res Appl Date: 2022-06-02
Authors: Denalee M O'Malley; Catherine M Alfano; Michelle Doose; Anita Y Kinney; Simon J Craddock Lee; Larissa Nekhlyudov; Paul Duberstein; Shawna V Hudson Journal: Transl Behav Med Date: 2021-11-30 Impact factor: 3.046
Authors: Rinad S Beidas; Shannon Dorsey; Cara C Lewis; Aaron R Lyon; Byron J Powell; Jonathan Purtle; Lisa Saldana; Rachel C Shelton; Shannon Wiltsey Stirman; Meghan B Lane-Fall Journal: Implement Sci Date: 2022-08-13 Impact factor: 7.960
Authors: Judith A Hannan; Yvonne Commodore-Mensah; Natsuko Tokieda; Alison P Smith; Kate Sustersic Gawlik; Linda Murakami; Jennifer Cooper; Susan Koob; Kathy D Wright; Doreen Cassarino; Cynthia Arslanian-Engoren; Bernadette Mazurek Melnyk Journal: Worldviews Evid Based Nurs Date: 2022-02-08 Impact factor: 4.347
Authors: Michaela Brtnikova; Jamie L Studts; Elise Robertson; L Miriam Dickinson; Jennifer K Carroll; Alex H Krist; John T Cronin; Russell E Glasgow Journal: BMC Prim Care Date: 2022-09-09